What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries

What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries

Bibliografische gegevens
Hoofdauteurs:	Coombs, C, Onakpoya, I, Mahtani, K, Aronson, J, O'Sullivan, J, Pluddemann, A, Heneghan, C
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	BMJ Publishing Group 2017

Gelijkaardige items

Ten essential papers for the practice of evidence-based medicine
door: Nunan, D, et al.
Gepubliceerd in: (2017)

A word about evidence: ‘rapid reviews’ or ‘restricted reviews’?
door: Aronson, J, et al.
Gepubliceerd in: (2018)

Introducing the EBM Verdict: research evidence relevant to clinical practice
door: Heneghan, C, et al.
Gepubliceerd in: (2019)

Redefining rapid reviews: a flexible framework for restricted systematic reviews
door: Plüddemann, A, et al.
Gepubliceerd in: (2018)

Transvaginal mesh failure: lessons for regulation of implantable devices.
door: Heneghan, C, et al.
Gepubliceerd in: (2017)

Lack of evidence for interventions offered in UK fertility centres
door: Heneghan, C, et al.
Gepubliceerd in: (2016)

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process.
door: Heneghan, C, et al.
Gepubliceerd in: (2017)

Commentary
door: Onakpoya, I, et al.
Gepubliceerd in: (2014)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
door: Onakpoya, I, et al.
Gepubliceerd in: (2016)

Developing evidence-based medicine in everyday practice
door: Heneghan, C
Gepubliceerd in: (2008)

Post-marketing regulation of medicines withdrawn from the market because of drug-attributed deaths: An analysis of justification.
door: Onakpoya, I, et al.
Gepubliceerd in: (2017)

Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
door: Onakpoya, I, et al.
Gepubliceerd in: (2017)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
door: Onakpoya, I, et al.
Gepubliceerd in: (2016)

Overdiagnosis: what it is and what it isn't.
door: Brodersen, J, et al.
Gepubliceerd in: (2018)

Evidence based medicine manifesto for better healthcare.
door: Heneghan, C, et al.
Gepubliceerd in: (2017)

Naltrexone‐bupropion (Mysimba®) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports
door: Onakpoya, IJ, et al.
Gepubliceerd in: (2020)

Diagnostic test guidelines based on high-quality evidence had greater rates of adherence: a meta-epidemiological study
door: O'Sullivan, J, et al.
Gepubliceerd in: (2018)

What is a 'complex systematic review'? Criteria, definition, and examples
door: Mahtani, K, et al.
Gepubliceerd in: (2018)

The first center for evidence-based medicine in Lithuania: an opportunity to change culture and improve clinical practice
door: Beinortas, T, et al.
Gepubliceerd in: (2015)

Welcome to BMJ Evidence-Based Medicine.
door: Heneghan, C
Gepubliceerd in: (2018)

The Pandemic EVIDENCE Collaboration Pillar 1: diagnostics and transmission
door: Conly, J, et al.
Gepubliceerd in: (2024)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
door: Onakpoya, IJ, et al.
Gepubliceerd in: (2016)

Editors’ response to concerns over the publication of the Cochrane HPV vaccine review was incomplete and ignored important evidence of bias
door: Heneghan, C, et al.
Gepubliceerd in: (2018)

Immunonutrition in clinical practice: what is the current evidence?
door: S. D. Heys, et al.

Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
door: Onakpoya, I, et al.
Gepubliceerd in: (2018)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
door: Onakpoya, I, et al.
Gepubliceerd in: (2017)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
door: Igho J. Onakpoya, et al.
Gepubliceerd in: (2019-03-01)

Verification bias
door: O'Sullivan, J, et al.
Gepubliceerd in: (2018)

Evidence-based Medicine Toolkit: Second Edition
door: Heneghan, C, et al.
Gepubliceerd in: (2008)

Evidence-based medicine: What it is, what it isn't, and why it is not evidence-biased medicine
door: Joseph L Mathew
Gepubliceerd in: (2023-01-01)

Oral hormone pregnancy tests and the risks of congenital malformations: A systematic review and meta-analysis
door: Heneghan, C, et al.
Gepubliceerd in: (2018)

The centre for evidence-based medicine 9th UK workshop
door: Heneghan, C
Gepubliceerd in: (2004)

Too much medicine: from evidence to action.
door: Moynihan, R, et al.
Gepubliceerd in: (2013)

Reduced salt intake for heart failure: A systematic review
door: Mahtani, K, et al.
Gepubliceerd in: (2018)

Limited evidence for diagnosing bacterial skin infections in older adults in primary care: systematic review
door: Gbinigie, O, et al.
Gepubliceerd in: (2019)

An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions
door: Onakpoya, I
Gepubliceerd in: (2017)

Evidence-base medicine - what is it?
door: Sh Erdes
Gepubliceerd in: (2003-04-01)

Evidence-Based Medicine?!... What for?
door: M. Peláez-Luna
Gepubliceerd in: (2012-10-01)

Evidence based medicine manifesto for better healthcare: A response to systematic bias, wastage, error and fraud in research underpinning patient care.
door: Heneghan, C, et al.
Gepubliceerd in: (2017)

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
door: Richards, GC, et al.
Gepubliceerd in: (2020)